Advertisement

Pain Management Protocols During Uterine Fibroid Embolisation: A Systematic Review of the Evidence

  • Affan Saibudeen
  • Gregory C. MakrisEmail author
  • Ahmed Elzein
  • Andrew Wigham
  • Rafiudin Patel
  • Mohammad Ali Husainy
  • Suzie Anthony
  • Raman Uberoi
Review

Abstract

Background

Uterine fibroid embolisation (UFE) is an effective treatment for fibroids. There are varying analgesia protocols published to control procedure associated pain. We aimed to assess what protocols are most effective in controlling post-procedural pain.

Materials and Methods

A systematic review of the Embase and Medline databases was conducted according to PRISMA guidelines. Studies regarding analgesia protocols post-uterine fibroid embolisation with Visual Analogue Scale or Numerical Rating Scale pain scores were included. The mean maximal pain scores of patients post-procedure were evaluated. ANOVA and t tests were performed.

Results

We identified 26 studies (total 3353 patients), with a mean procedural success rate of > 87%. We stratified protocols into four groups. Mean pain scores were: opioids ± NSAIDs ± acetaminophen (4.84, SD = 1.56); opioids ± NSAIDs ± acetaminophen + nerve block (4.7, SD = 1.37); opioids ± NSAIDs ± acetaminophen + intrauterine artery drug administration (4.09, SD = 0.60); and opioids ± NSAIDs ± acetaminophen + other (5.30, SD = 1.13) without significant difference between groups (p = 0.71). Similarly, there was no difference (p = 0.057) between groups for time to discharge or side effects.

Conclusions

There is no evidence to suggest that there is any superiority of one protocol above another in the published literature. Appropriate use of opioids ± NSAIDs ± acetaminophen alone appears to be sufficient to control pain post-UFE. However, due to large heterogeneity of the literature no firm conclusions can be reached, and further research is warranted.

Level of Evidence

Level 1, Systematic review.

Keywords

Uterine artery embolisation Fibroids Pain management 

Notes

Compliance with Ethical Standards

Conflict of interest

The authors declare they have no conflict of interest.

Ethical Approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed Consent

For this type of study, informed consent is not required.

Consent for Publication

For this type of study, consent for publication is not required.

References

  1. 1.
    Fujii S, et al. Fibroids: basic science and etiology. Int Congr Ser. 2004;1266:183–90.CrossRefGoogle Scholar
  2. 2.
    Ravina JH, Ciraru-Vigneron N, Bouret JM, Herbreteau D, Houdart E, Aymard A, Merland JJ. Arterial embolisation to treat uterine myomata. Lancet. 1995;364:671–2.CrossRefGoogle Scholar
  3. 3.
    Gupta JK, Sinha A, Lumsden MA, Hickey M. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database Syst Rev. 2014.  https://doi.org/10.1002/14651858.CD005073.pub4.Google Scholar
  4. 4.
    Bilhim T, Pisco JM. The role of nonsteroidal anti-inflammatory drugs (NSAIDS) in the management of the post-embolization symptoms after uterine artery embolization. Pharmaceuticals. 2010;3:1729–38.CrossRefGoogle Scholar
  5. 5.
    Lipszyc M, Winters E, Engelman E, Baurain M, Barvais L. Remifentanil patient-controlled analgesia effect-site target-controlled infusion compared with morphine patient-controlled analgesia for treatment of acute pain after uterine artery embolization. Br J Anaesth. 2011;106:724–31.CrossRefGoogle Scholar
  6. 6.
    Siskin GP, Stainken BF, Dowling K, Meo P, Ahn J, Dolen EG. Outpatient uterine artery embolization for symptomatic uterine fibroids: experience in 49 patients. J Vasc Interv Radiol. 2000;11:305–11.CrossRefGoogle Scholar
  7. 7.
    Nemcek AA, Sichlau M, Vogelzang R. Comparison of pain after uterine artery embolization using tris-acryl gelatin microspheres versus polyvinyl alcohol particles. Cardiovasc Intervent Radiol. 2004;26:375–8.Google Scholar
  8. 8.
    Katsumori T, Arima H, Asai S, Hayashi N, Miura H. Comparison of pain within 24 h after uterine artery embolization with tris-acryl gelatin microspheres versus gelatin sponge particles for leiomyoma. Cardiovasc Intervent Radiol. 2017;40:1687–93.CrossRefGoogle Scholar
  9. 9.
    Chiu CY, Wong WK, Mak HL, Chan CS, Kwok CH, Chan CH, Chan MK. Uterine artery embolisation for treatment of fibroids: experience in Chinese women. Singap Med J. 2001;42:148–54.Google Scholar
  10. 10.
    Kim HS, Czuczman GJ, Nicholson WK, Pham LD, Richman JM. Pain levels within 24 hours after UFE: a comparison of morphine and fentanyl patient-controlled analgesia. Cardiovasc Intervent Radiol. 2008;31:1100–7.CrossRefGoogle Scholar
  11. 11.
    McCullough M, et al. Polyvinyl alcohol particles and tris-acryl gelatin microspheres for uterine artery embolization for leiomyomas: results of a randomized comparative study. J Vasc Interv Radiol. 2012;15:793–800.Google Scholar
  12. 12.
    Rasuli P, et al. Outpatient uterine artery embolization for symptomatic fibroids: short- and long-term single institution-based outcomes. J Obstet Gynaecol Canada. 2013;35:156–63.CrossRefGoogle Scholar
  13. 13.
    Barnard EP, et al. Periprocedural outcomes comparing fibroid embolization and focused ultrasound: a randomized controlled trial and comprehensive cohort analysis. Am J Obs Gynecol. 2017;216:87–97.Google Scholar
  14. 14.
    Tran C, et al. Tolerance, hospital stay, and recovery after uterine artery embolization for fibroids: the Ontario uterine fibroid embolization trial. J Vasc Interv Radiol. 2012;14:1243–50.Google Scholar
  15. 15.
    Cunningham E, Barreda L, Ngo M, Terasaki K, Munro MG. Uterine artery embolization versus occlusion for uterine leiomyomas: a pilot randomized clinical trial. J Minim Invasive Gynecol. 2008;15:301–7.CrossRefGoogle Scholar
  16. 16.
    Jensen LL, et al. No morphine sparing effect of ketamine added to morphine for patient-controlled intravenous analgesia after uterine artery embolization. Acta Anaesthesiol Scand. 2008;52:479–86.CrossRefGoogle Scholar
  17. 17.
    Pisco JM, Bilhim T, Duarte M, Santos D. Management of uterine artery embolization for fibroids as an outpatient procedure. J Vasc Interv Radiol. 2009;20:730–5.CrossRefGoogle Scholar
  18. 18.
    Manninen H, Hippeläinen M, Ruuskanen A, Sipola P, Wüstefeld M. Pain after uterine fibroid embolisation is associated with the severity of myometrial ischaemia on magnetic resonance imaging. Eur Radiol. 2009;19:2977–85.CrossRefGoogle Scholar
  19. 19.
    Konstantatos AH, et al. A randomized, double-blind, placebo-controlled study of preemptive oral oxycodone with morphine patient-controlled anesthesia for postoperative pain management in patients undergoing uterine artery embolization for symptomatic uterine fibroids. Cardiovasc Intervent Radiol. 2014;37:1191–7.CrossRefGoogle Scholar
  20. 20.
    Roth AR, et al. Pain after uterine artery embolization for leiomyomata: can its severity be predicted and does severity predict outcome? J Vasc Interv Radiol. 2007;11:1047–52.CrossRefGoogle Scholar
  21. 21.
    Yoon J, et al. Superior hypogastric nerve block as post-uterine artery embolization analgesia: a randomized and double-blind clinical trial. Radiology. 2018;289:248–54.CrossRefGoogle Scholar
  22. 22.
    Pisco JM, Tsuchiya M, Bilhim T, Duarte M, Santos D, Oliveira AG. Uterine artery embolization under electroacupuncture for uterine leiomyomas. J Vasc Interv Radiol. 2009;20(7):863–70.CrossRefGoogle Scholar
  23. 23.
    Freire GMG, et al. Controlled-release oxycodone improves pain management after uterine artery embolisation for symptomatic fibroids. Clin Radiol. 2017.  https://doi.org/10.1016/j.crad.2016.12.010.Google Scholar
  24. 24.
    Rasuli P, et al. Superior hypogastric nerve block for pain control in outpatient uterine artery embolization. J Vasc Interv Radiol. 2004;15:1423–9.CrossRefGoogle Scholar
  25. 25.
    Hehenkamp WJK, Volkers NA, Birnie E, Reekers JA, Ankum WM. Pain and return to daily activities after uterine artery embolization and hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial. Cardiovasc Intervent Radiol. 2006;29:179–87.CrossRefGoogle Scholar
  26. 26.
    Keyoung JA, et al. Intraarterial lidocaine for pain control after uterine artery embolization for leiomyomata. J Vasc Interv Radiol. 2001;12:1065–9.CrossRefGoogle Scholar
  27. 27.
    Noel-Lamy M, et al. Intraarterial lidocaine for pain control in uterine artery embolization: a prospective, randomized study. J Vasc Interv Radiol. 2017;28:16–22.CrossRefGoogle Scholar
  28. 28.
    Bilhim T, Pisco JM, Duarte M, Oliveira AG. Polyvinyl alcohol particle size for uterine artery embolization: a prospective randomized study of initial use of 350–500 μm particles versus initial use of 500–700 μm particles. J Vasc Interv Radiol. 2011;22:21–7.CrossRefGoogle Scholar
  29. 29.
    Kim SY, et al. Comparison of the efficacy of dexmedetomidine plus fentanyl patient-controlled analgesia with fentanyl patient-controlled analgesia for pain control in uterine artery embolization for symptomatic fibroid tumors or adenomyosis: a prospective, randomized st. J Vasc Interv Radiol. 2013;24:779–86.CrossRefGoogle Scholar
  30. 30.
    Kim SY, et al. The effects of single-dose dexamethasone on inflammatory response and pain after uterine artery embolisation for symptomatic fibroids or adenomyosis: a randomised controlled study. BJOG An Int J Obstet Gynaecol. 2016;123:580–7.CrossRefGoogle Scholar
  31. 31.
    Plancarte R, de Leon-Casasola OA, El-Helaly M, Allende S, Lema MJ. Neurolytic superior hypogastric plexus block for chronic pelvic pain associated with cancer. Reg Anesth. 1997;22(6):562–8.Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2019

Authors and Affiliations

  • Affan Saibudeen
    • 1
  • Gregory C. Makris
    • 2
    • 3
    Email author
  • Ahmed Elzein
    • 2
  • Andrew Wigham
    • 2
  • Rafiudin Patel
    • 2
  • Mohammad Ali Husainy
    • 2
  • Suzie Anthony
    • 2
  • Raman Uberoi
    • 2
  1. 1.University of OxfordOxfordUK
  2. 2.Vascular and Interventional Radiology DepartmentOxford University Hospitals, NHS Foundation TrustOxfordUK
  3. 3.Alfa Institute of Biomedical SciencesMarousiGreece

Personalised recommendations